CCM Investment Advisers LLC Reduces Position in UnitedHealth Group Incorporated (NYSE:UNH)

CCM Investment Advisers LLC trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.3% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 31,271 shares of the healthcare conglomerate's stock after selling 1,075 shares during the period. UnitedHealth Group accounts for 2.0% of CCM Investment Advisers LLC's portfolio, making the stock its 19th largest holding. CCM Investment Advisers LLC's holdings in UnitedHealth Group were worth $16,378,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Geode Capital Management LLC raised its stake in UnitedHealth Group by 1.6% during the 4th quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock valued at $10,068,869,000 after purchasing an additional 319,515 shares during the period. Capital International Investors grew its stake in UnitedHealth Group by 6.2% during the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock valued at $7,899,905,000 after acquiring an additional 906,365 shares in the last quarter. Norges Bank bought a new position in shares of UnitedHealth Group during the 4th quarter valued at about $6,375,744,000. Northern Trust Corp boosted its stake in UnitedHealth Group by 12.5% during the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock valued at $4,807,527,000 after buying an additional 1,058,488 shares during the last quarter. Finally, Franklin Resources Inc. boosted its position in shares of UnitedHealth Group by 10.7% during the 4th quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock valued at $4,514,178,000 after acquiring an additional 861,854 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Insider Buying and Selling

In other news, CEO Patrick Hugh Conway sold 589 shares of the business's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer now directly owns 10,398 shares in the company, valued at $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Kristen Gil acquired 3,700 shares of the firm's stock in a transaction on Thursday, May 15th. The shares were bought at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the acquisition, the director now owns 3,818 shares of the company's stock, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought 109,408 shares of company stock worth $31,607,768 in the last 90 days. Insiders own 0.28% of the company's stock.

Analysts Set New Price Targets

UNH has been the subject of a number of recent research reports. Wall Street Zen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. Truist Financial reiterated a "buy" rating and issued a $360.00 target price (down previously from $580.00) on shares of UnitedHealth Group in a report on Monday, May 19th. TD Securities reaffirmed a "hold" rating and set a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Wolfe Research dropped their price target on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a research note on Tuesday, May 20th. Finally, Piper Sandler decreased their price objective on shares of UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating for the company in a research note on Tuesday, June 3rd. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of "Moderate Buy" and a consensus price target of $426.52.

UnitedHealth Group Stock Down 1.6%

Shares of NYSE:UNH traded down $5.11 during trading on Friday, reaching $313.39. The stock had a trading volume of 13,729,200 shares, compared to its average volume of 7,185,786. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The firm's 50-day simple moving average is $386.66 and its 200 day simple moving average is $474.19. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $284.28 billion, a P/E ratio of 20.22, a PEG ratio of 1.37 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. During the same quarter in the prior year, the company posted $6.91 EPS. As a group, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be paid a dividend of $2.21 per share. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date is Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.82%. UnitedHealth Group's dividend payout ratio is presently 37.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.